I wanted to share with You this findings and at the same time ask about any thoughts
i.e. are there some reasons that this wont work & etc. ?
Here the findings:
Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells.
Among transcription factors involved in the element, telmisartan significantly induced NGFIB/NURR1 expression. [*]
KN-93, a CaMK inhibitor, abrogated the telmisartan-mediated increase of CYP11B2 transcription/mRNA expression and NURR1 mRNA expression, but not NGFIB mRNA expression.
http://www.ncbi.nlm....pubmed/24333837
Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice
Telmisartan (TEL), an angiotensin type 1 receptor (AT1R) antagonist, has been reported to exert neuroprotective effect in animal models of Parkinson's disease (PD). However, its effect on motor functions, mutant protein α-synuclein (SYN) and neurotrophic factors (BDNF and GDNF) expression and their interrelation in PD has not yet been elucidated. In the present study, the effect of TEL on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced motor dysfunctions and dopaminergic degeneration was ascertained through investigating the alterations in protein expression of dopamine transporter (DAT), tyrosine hydroxylase (TH) and SYN in C57BL/6J mouse. Further, the role of TEL on the gene expression of neurotrophic factors such as BDNF and GDNF and protein expression of vesicular monoamine transporter 2 (VMAT2) and Glial fibrillary acidic proteins (GFAP) were studied. In TEL treated mouse, strong negative correlation was observed between motor function and SYN, while a strong positive correlation was noted with BDNF and GDNF expression. TEL caused down-regulation of SYN, GFAP and up-regulation of DAT, TH, VAMT2, BDNF and GDNF expressions. Present data suggest that brain renin angiotensin system (RAS) plays a crucial role in motor function and in the regulation of key proteins such as SYN, BDNF and GDNF, DAT, TH, VMAT2 and GFAP in Parkinsonism. In conclusion, the present study shows that angiotensin type 1 receptor antagonists can ameliorate motor dysfunction and act as potential neuroprotective agent in the management of Parkinsonism.
http://www.pubfacts....hrough-regulati
[*]
Nurr1 regulates RET expression in dopamine neurons of adult rat midbrain
http://www.ncbi.nlm....pubmed/20533997
RET seems to be a target of GDNF
http://en.wikipedia...._proto-oncogene
Btw I´ve found that DJ-1 is also upregulating Vmat2
DJ-1 protects against dopamine toxicity: implications for Parkinson's disease and aging.
http://www.ncbi.nlm....pubmed/22887838
And Sodium- or Natrium Benzoate ( alias Food perservative E211) activates it:
Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons.
http://www.ncbi.nlm....pubmed/21701815
What are You thoughts on E211. Will it Work if ingested ?
Edit:
Valproic acid does also increase Nurr1 ( and CDNF ) mRNA
Induction of neurotrophic and differentiation factors in neural stem cells by valproic acid.
http://www.ncbi.nlm....pubmed/24460582
Edited by Flex, 30 August 2014 - 12:10 AM.